Abstract
Cancer is not rare in younger women of reproductive age therefore the preservation of fertility among them has become a significant concern due to aggressive cancer therapy they must undergo. Today different strategies for fertility preservation are available in patients at risk. However, many of these available techniques are still experimental and have limited clinical experience. Under ethical principle, better interdisciplinary cooperation between clinicians and patients, appropriate counseling and further research on cryopreservation and transplantation techniques may enhance their success to preserve fertility of young cancer victims. In this article, the existing and emerging fertility preserving strategies in young cancer female as well as their safety and ethical issues are discussed.
Similar content being viewed by others
References
Chang HJ, Shu CS. Fertility preservation for women with malignancies: current developments of cryopreservation. J Gynecol Oncol, 2008, 19: 99–107.
Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin, 2009, 59: 225–249.
Sonmezer M, Oktay K. Fertility preservation in female patients. Hum Reprod Update, 2004, 10: 251–266.
Marhhom E, Cohen I. Fertility preservation options for women with malignancies. Obstet Gynecol Surv, 2007, 62: 58–72.
Jeruss JS, Woodruff TK. Preservation of fertility in patients with cancer. N Engl J Med, 2009, 360: 902–911.
Oehninger S. Strategies for fertility preservation in female and male cancer survivors. J Soc Gynecol Investig, 2005, 12: 222–231.
Seli E, Tangir J. Fertility preservation options for female patients with malignancies. Curr Opin Obstet Gynecol, 2005, 17: 299–308.
Oktay K, Buyuk E, Davis O, et al. Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum Reprod, 2003, 18: 90–95.
Klijn JG, Beex LV, Mauriac L, et al. Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: a randomized study. J Nat Cancer Inst, 2000, 92: 903–911.
Pfister CU, Martoni A, Zamagni C, et al. Effect of age and single versus multiple dose pharmacokinetics of letrozole (Femara) in breast cancer patients. Biopharm Drug Dispos, 2001, 22: 191–197.
Wallace WH, Anderson R, Baird D. Preservation of fertility in young women treated for cancer. Lancet Oncol, 2004, 5: 269–270.
Practice committee of the American Society for Reproductive Medicine, Practice Committee of the Society for Assisted Reproduction Technology. Ovarian tissue and oocyte cryopreservation. Fertil Steril, 2006, 86: S142–147.
Chen C. Pregnancy after human oocyte cryopreservation. Lancet, 1986, 1: 884–886.
Ezcurra D, Rangnow J, Craig M, et al. The human oocyte preservation experience (HOPE) a phase IV, prospective, multicenter, observational oocyte cryopreservation registry. Reprod Biol Endocrinol, 2009, 7: 53.
Porcu E, Fabbri R, Seracchioli R, et al. Birth of a healthy female after intracytoplasmic sperm injection of cryopreserved human oocytes. Fertil Steril, 1997, 68: 724–726.
Katayama KP, Stehlik J, Kuwayama M. High survival rate of vitrified human oocytes results in clinical pregnancy. Fertil Steril, 2003, 80: 223–224.
Yoon TK, Kim TJ, Park SE, et al. Live births after vitrification of oocytes in a stimulated in vitro fertilization-embryo transfer program. Fertil Steril, 2003, 79: 1323–1326.
Borini A, Bonu MA, Coticchio G, et al. Pregnancies and births after oocyte cryopreservation. Fertil Steril, 2004, 82: 601–605.
Porcu E. Oocyte freezing. Semin Reprod Med, 2001, 19: 221–230.
Tucker M, Wright G, Morton P, et al. Preliminary experience with human oocyte cryopreservation using 1,2-propanediol and sucrose. Hum Reprod, 1996, 11: 1513–1515.
Gook DA, Schiewe MC, Osborn SM, et al. Intracytoplasmic sperm injection and embryo development of human oocytes cryopreserved using 1, 2-propanediol. Hum Reprod, 1995, 10: 2637–2641.
Fabbri R, Porcu E, Marsella T, et al. Human oocyte cryopreservation: new perspectives regarding oocyte survival. Hum Reprod, 2001, 16:411–416.
Eroglu A, Toner M, Toth TL. Beneficial effect of microinjected trehalose on the cryosurvival of human oocytes. Fertil Steril, 2002, 77: 152–158.
Chang CC, Shapiro DB, Bernal DP, et al. Human oocyte vitrification: in-vivo and in-vitro maturation outcomes. Reprod Biomed Online, 2008, 17: 684–688.
Strassburger D, Friedler S, Raziel A, et al. The outcome of ICSI of immature MI oocytes and rescued in vitro matured MII oocytes. Hum Reprod, 2004, 19: 1587–1590.
Otsuki J, Momma Y, Takahashi K, et al. Timed IVM followed by ICSI in a patient with immature ovarian oocytes. Reprod Biomed Online, 2006, 13: 101–103.
Vanhoutte L, De Sutter P, Van der Elst J, et al. Clinical benefit of metaphase I oocytes. Reprod Biol Endocrinol, 2005, 3: 71.
Donnez J, Martinez-Madrid B, Jadoul P, et al. Ovarian tissue cryopreservation and transplantation: a review. Hum Reprod Update, 2006, 12: 519–535.
Gosden RG, Baird DT, Wade JC, et al. Restoration of fertility to oophorectomized sheep by ovarian autografts stored at -196 degrees C. Hum Repord, 1994, 9: 597–603.
Kim SS, Lee WS, Chung MK, et al. Long-term ovarian function and fertility after heterotopic autotransplantation of cryobanked human ovarian tissue: 8-year experience in cancer patients. Fertil Steril, 2009, 91: 2349–2354.
Donnez J, Squifflet J, Dolmans MM. Frozen-thawed ovarian tissue retransplants. Semin Reprod Med, 2009, 27: 472–478.
Oktay K, Newton H, Godsen RG. Transplantation of cryopreserved human ovarian tissue results in follicle growth initiation in SCID mice. Fertil Steril, 2000, 73: 599–603.
Salle B, Demirci B, Franck M, et al. Normal pregnancies and live births after autograft of frozen-thawed hemi-ovaries into ewes. Fertil Steril, 2002, 77: 403–408.
Lee DM, Yeoman RR, Battaglia DE, et al. Live birth after ovarian tissue transplant. Nature, 2004, 428: 137–138.
Oktay K, Buyuk E, Rosenwakes Z, et al. A technique for transplantation of ovarian cortical stripes to the forearm. Fertil Steril, 2003, 80:193–198.
Kim SS, Battaglia DE, Soules MR. The future of human ovarian cryopreservation and transplantation: fertility and beyond. Fertil Steril, 2001, 75: 1049–1056.
Meirow D, Levron J, Eldar-Geva T, et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med, 2005, 353: 318–321.
Demeestere I, Simon P, Emiliani S, et al. Fertility preservation: successful transplantation of cryopreserved ovarian tissue in a young patient previously treated for Hodgkin’s disease. Oncologist, 2007, 12: 1437–1442.
Andersen CY, Rosendahl M, Byskov AG, et al. Two successful pregnancies following autotransplantation of frozen/thawed ovarian tissue. Hum Reprod, 2008, 23: 2266–2272.
Kim SS, Hwang IT, Lee HC. Heterotopic autotransplantation of cryobanked human ovarian tissue as a strategy to restore ovarian function. Fertil Steril, 2004, 82: 930–932.
Donnez J, Dolmans MM, Demylle D, et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet, 2004, 364: 1405–1410.
Oktay K, Buyuk E, Veeck L, et al. Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet, 2004, 363: 837–840.
Radford JA, Lieberman BA, Brison DR, et al. Orthotopic reimplantation of cryopreserved ovarian cortical stripes after high-dose chemotherapy for Hodgkin’s lymphoma. Lancet, 2001, 357: 1172–1175.
Wolner-Hanseen P, Hägglund L, Ploman F, et al. Autotransplantation of cryopreserved ovarian tissue to the right forearm 4 (1/2) years after autologous stem cell transplantation. Acta Obstet Gynecol Scand, 2005, 84: 695–698.
Oktay K, Newton H, Mullan I, et al. Development of human primordial follicles to antral stages in SCID/hpg mice stimulated with follicle stimulating hormone. Hum Reprod, 1998, 13: 1133–1138.
Gook DA, Osborn SM, Archer J, et al. Follicle development following cryopreservation of human ovarian tissue. Eur J Obstet Gynecol Reprod Biol, 2004, 113: S60–62.
Lucifero D, Mertineit C, Clarke HJ, et al. Methylation dynamics of imprinted genes in mouse germ cells. Genomics, 2002, 79: 530–538.
Abir R, Fisch B, Nitke S, et al. Morphological study of fully and partially isolated early human follicles. Fertil Steril, 2001, 75: 141–146.
Laschke MW, Menger MD, Vollmar B. Ovariectomy improves neovascularization and microcirculation of freely transplanted ovarian follicles. J Endocrinol, 2002, 172: 535–544.
Liu J, Van der Elst J, Van den Broecke R, et al. Early massive follicle loss and apoptosis in heterotopically grafted newborn mouse ovaries. Hum Reprod, 2002, 17: 605–611.
Wang X, Chen H, Yin H, et al. Fertility after intact ovary transplantation. Nature, 2002, 415: 385.
Bedaiwy MA, Jeremias E, Gurunluoglu R, et al. Restoration of ovarian function after autotransplantation of intact frozen-thawed sheep ovaries with microvascular anastomosis. Fertil Steril, 2003, 79:594–602.
Martinez-Madrid B, Dolmans MM, Van Langendonckt A, et al. Freezethawing intact human ovary with its vascular pedicle with a passive cooling device. Fertil Steril, 2004, 82: 1390–1394.
Bedaiwy MA, Hussein MR, Biscotti C, et al. Cryopreservation of intact human ovary with its vascular pedicle. Hum Reprod, 2006, 21: 3258–3269.
Bedaiwy MA. Strategies for fertility preservation and gonadal protection during gonadotoxic chemotherapy and radiotherapy. Middle East Fertil Soc J, 2005, 10: 1–21.
Cancer and pregnancy. Methods for fertility preservation. Available: http://www.cancerinpregnancy.org/node/61, 24th May, 2010.
Morita Y, Tilly JL. Oocyte apoptosis: like sand through an hourglass. Dev Biol, 1999, 213: 1–17.
Morita Y, Perez GI, Paris F, et al. Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat Med, 2000, 6: 1109–1114.
Paris F, Perez GI, Fuks Z, et al. Sphingosine-1-phosphate preserves fertility in irradiated female mice without propagating genomic damage in offspring. Nat Med, 2002, 8: 901–902.
Shaw JM, Bowels J, Koopman P, et al. Fresh and cryopreserved ovarian tissue samples from donors with lymphoma transmit the cancer to graft recipients. Hum Reprod, 1996, 11: 1668–1673.
Meirow D, Hardan I, Dor J, et al. Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients. Hum Reprod, 2008, 23: 1007–1013.
Liede A, Narod SA. Hereditary breast and ovarian cancer in Asia: Genetic epidemiology of BRCA1 and BRCA2. Hum Mutat, 2002, 20: 413–424.
Dudzinski DM. Ethical issues in fertility preservation for adolescent cancer survivors: oocyte and ovarian tissue cryopreservation. J Pediatr Adolesc Gynecol, 2004, 17: 97–102.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Jafarey, R., Yang, J. & Li, S. Fertility preservation in female cancer patients. Chin. -Ger. J. Clin. Oncol. 10, 1–8 (2011). https://doi.org/10.1007/s10330-011-0656-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10330-011-0656-3